Introduction: The role of antibiotic prophylaxis for routine flexible cystoscopy (FC) is not clear due to the varying practices of individual clinicians. There are no formal guidelines, and this may be due to a lack of formal summary of the data. Methods: A systematic review was conducted in April 2014 including all randomised control trials on prophylactic antibiotic use for FC. The main outcome measures were confirmed bacteriuria on mid-stream urine (MSU), asymptomatic bacteriuria and symptomatic bacteriuria. A meta-analysis was conducted with difference between groups expressed as an odds ratio (OR) and control group risk. Results: 5,107 patients were included, 2,173 in placebo and 2,934 in the antibiotic group. The OR for all three outcomes favoured the antibiotic group; the risk of developing symptomatic bacteriuria was 0.06 times more likely in the control group (OR 0.34), 0.054 (OR 0.40) for developing asymptomatic bacteriuria and 0.109 for confirming bacteriuria on MSU (OR 0.36). The number needed to treat (NNT) was 15 (13-19) for MSU positive bacteriuria; 32 (27-42) for symptomatic bacteriuria and 26 (23-33) for asymptomatic bacteriuria. Conclusions: Antibiotic prophylaxis did confer a reduction in cases of symptomatic and asymptomatic bacteriuria but the NNT were high. Therefore, the authors cannot advocate the use of antibiotic prophylaxis for routine FC procedures.

Keywords:
Antibiotic prophylaxis, Flexible cystoscopy, Urinary tract infection
1.
Fowler CG: Fibrescope urethrocystoscopy. Br J Urol 1984;56:304-307.
2.
Grasso M, Beaghler M, Bagley DH, Strup S: Actively deflectable, flexible cystoscopes: no longer solely a diagnostic instrument. J Endourol 1993;7:527-530.
3.
Cohen BL, Rivera R, Barboglio P, Gousse A: Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. J Urol 2007;177:1006-1010; discussion 1010.
4.
Almallah YZ, Rennie CD, Stone J, Lancashire MJ: Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology 2000;56:37-39.
5.
Cundiff GW, Mclennan MT, Bent AE: Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. Obstet Gynecol 1999;93:749-752.
6.
Olson ES, Cookson BD: Do antimicrobials have a role in preventing septicaemia following instrumentation of the urinary tract? J Hosp Infect 2000;45:85-97.
7.
Rané A, Cahill D, Saleemi A, Montgomery B, Palfrey E: The issue of prophylactic antibiotics prior to flexible cystoscopy. Eur Urol 2001;39:212-214.
8.
Burke DM, Shackley DC, O'Reilly PH: The community-based morbidity of flexible cystoscopy. BJU Int 2002;89:347-349.
9.
Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A: Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 2008;54:1270-1286.
10.
Alsaywid BS, Smith GH: Antibiotic prophylaxis for transurethral urological surgeries: systematic review. Urol Ann 2013;5:61-74.
11.
García-Perdomo HA, López H, Carbonell J, Castillo D, Cataño JG, Serón P: Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: a randomized clinical trial. World J Urol 2013;31:1433-1439.
12.
Jiménez-Pacheco A, Lardelli Claret P, López Luque A, Lahoz-García C, Arrabal Polo MA, Nogueras Ocaña M: Randomized clinical trial on antimicrobial prophylaxis for flexible urethrocystoscopy. Arch Esp Urol 2012;65:542-549.
13.
Jiménez Cruz JF, Sanz Chinesta S, Otero G, Díaz González R, Alvarez Ruiz F, Flores N, et al: [Antimicrobial prophylaxis in urethrocystoscopy. Comparative study]. Actas Urol Esp 1993;17:172-175.
14.
Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ: Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis. Baltimore, American Urological Association, 2007, p 45.
15.
Grabe M, Bartoletti R, Bjerklund-Johansen TE, Çek HM, Pickard RS, Tenke P, Wagenlehner F, Wullt B: Guidelines on Urological Infections. European Association of Urology, 2014. http://www.uroweb.org/guidelines/ (accessed June 2014).
16.
Higgins JPT, Altman DG (eds): Chapter 8: assessing risk of bias in included studies; in Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008. www.cochrane-handbook.org (accessed February 10, 2011).
17.
Johnson MI, Merrilees D, Robson WA, Lennon T, Masters J, Orr KE, Matthews JN, Neal DE: Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int 2007;100:826-829.
18.
Mendoza GB Jr, Gerwig WH Jr, Stackhouse KL, Easley GW: Prophylactic use of antibacterial drugs following cystoscopy: a double-blind controlled study of demeclocycline hydrochloride and sulfamethoxypyridazine. J Urol 1971;106:682-684.
19.
Wilson L, Ryan J, Thelning C, Masters J, Tuckey J: Is antibiotic prophylaxis required for flexible cystoscopy? A truncated randomized double-blind controlled trial. J Endourol 2005;19:1006-1008.
20.
Lo TS, Khanuengkitkong S, Tan YL, Dass AK, Wu PY, Al-kharabsheh AM: Low incidence of bacteriuria with outpatient flexible cystoscopy. Aust N Z J Obstet Gynaecol 2014;54:366-370.
21.
Herr HW: Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria. BJU Int 2012;110:E658-E660.
22.
Alsaywid BS, Smith GH: Antibiotic prophylaxis for transurethral urological surgeries: systematic review. Urol Ann 2013;5:61-74.
23.
Wagenlehner FM, Thomas PM, Naber KG: Fosfomycin trometamol (3,000 mg) in perioperative antibiotic prophylaxis of healthcare-associated infections after endourological interventions: a narrative review. Urol Int 2014;92:125-130.
24.
Hori S, Kennedy CL: Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int 2008;101:257.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.